Tokyo, Oct. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058431) titled 'Clinical recarch of 3D-printed Spinal Orthoses for practical use' on Oct. 14.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Niigata University of Health and Welfare

Condition: Condition - Healthy people Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - In recent years, the development of 3D printers has led to their use in the fabrication of spinal orthoses prescribed for the treatment of patients with spinal disorders. Because 3D printers can rapidly fabricate prostheteses and orthoses, it is expected that they will improve the effectiveness of treatment, shorten hospital stays, and reduce medical costs.However, spinal orthoses fabricated with 3D printers (hereinafter referred to as 3D-printed spinal orthoses) have not been shown to have the same strength, durability, wearability, and safety in terms of their effects on the skin as spinal orthoses fabricated using conventional methods (hereinafter referred to as conventional spinal orthoses).Therefore, the purpose of this study is to produce 3D-printed spinal orthoses for five healthy adults and verify them. Basic objectives2 - Safety

Intervention: Interventions/Control_1 - Wear for 9 months. Wear for 3 hours per day.

Eligibility: Age-lower limit - 40 years-old = Gender - Male Key inclusion criteria - Being healthy Key exclusion criteria - If you experience pain when wearing the Orthosis Target Size - 5

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 08 Month 01 Day Anticipated trial start date - 2025 Year 09 Month 01 Day Last follow-up date - 2026 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066808

Disclaimer: Curated by HT Syndication.